Abstract:BACKGROUND:Chronic itch is a highly debilitating symptom that underlies many medical disorders with no universally effective treatments. Although unique neuronal signaling cascades in the sensory ganglia and spinal cord have been shown to critically promote the pathogenesis of chronic itch, the role of skin-associated cells remains poorly understood. OBJECTIVE:We sought to examine the cutaneous mechanisms underlying transient receptor potential vanilloid 4 (TRPV4)-mediated allergic and nonallergic chronic itch. METHODS:Expression of TRPV4 in chronic itch and healthy control skin preparations was examined by using real-time RT-PCR. Trpv4eGFP mice were used to study the expression and function of TRPV4 in the skin by means of immunofluorescence staining, flow cytometry, calcium imaging, and patch-clamp recordings. Genetic and pharmacologic approaches were used to examine the role and underlying mechanisms of TRPV4 in mouse models of dry skin-associated chronic itch and spontaneous scratching associated with squaric acid dibutylester-induced allergic contact dermatitis. RESULTS:TRPV4 is selectively expressed by dermal macrophages and epidermal keratinocytes in mice. Lineage-specific deletion of TRPV4 in macrophages and keratinocytes reduces allergic and nonallergic chronic itch in mice, respectively. Importantly, TRPV4 expression is significantly increased in skin biopsy specimens from patients with chronic idiopathic pruritus in comparison with skin from healthy control subjects. Moreover, TRPV4-dependent chronic itch requires 5-hydroxytryptamine (5-HT) signaling secondary to activation of distinct 5-HT receptors in mice with allergic and those with nonallergic chronic itch conditions. CONCLUSION:Our study reveals previously unrecognized mechanisms by which TRPV4-expressing epithelial and immune cells in the skin critically and dynamically mediate chronic itch and unravels novel targets for therapeutics in the setting of chronic itch.

A basophil-neuronal axis promotes itch

Neuronal IL-4Rα and JAK1 Signaling Critically Mediate Atopic Dermatitis-Associated

Neuronal BST2: A Pruritic Mediator Alongside PAR2 in the Interleukin-27-Driven Itch Pathway

Chronic itch development in sensory neurons requires BRAF signaling pathways.

Sensory neuron–expressed TRPC3 mediates acute and chronic itch

Sensitization Mechanisms of Chronic Itch

Molecular and cellular mechanisms of itch sensation and the anti-itch drug targets

Mechanisms of the PD-1/PD-L1 pathway in itch: From acute itch model establishment to the role in chronic itch in mouse

A γδ T cell-IL-3 axis controls allergic responses through sensory neurons

MrgprA3+ Primary Sensory Neurons Mediate Acute Allergic Itch Responses in Atopic Dermatitis Model Mice

More Than Scratching the Surface: Recent Progress in Brain Mechanisms Underlying Itch and Scratch

The Challenge of Basic Itch Research

Transient receptor potential vanilloid 4-expressing macrophages and keratinocytes contribute differentially to allergic and nonallergic chronic itch.

An Anterior Cingulate Cortex-to-Midbrain Projection Controls Chronic Itch in Mice

Common and discrete mechanisms underlying chronic pain and itch: peripheral and central sensitization

Annexin 1 Reduces Dermatitis-Induced Itch and Cholestatic Itch through Inhibiting Neuroinflammation and Iron Overload in the Spinal Dorsal Horn of Mice

Chemokine Receptor CXCR3 in the Spinal Cord Contributes to Chronic Itch in Mice

Antioxidants Attenuate Acute and Chronic Itch: Peripheral and Central Mechanisms of Oxidative Stress in Pruritus

Clinically uninvolved but not healthy-The skin of patients with atopic dermatitis is primed for itch and inflammation

Cell Type‐Specific Modulation of Acute Itch Processing in the Anterior Cingulate Cortex

The Lateral Habenula Nucleus Regulates Pruritic Sensation and Emotion.